Loading candles…
Aspira Pathlab & Diagnostics Ltd, incorporated in 1973, operates in the healthcare, diagnostics, and pathology industries primarily within Maharashtra, India. The company provides pathology and related healthcare diagnostic services, including pathology, radiology, and advanced diagnostic testing, catering to individual patients, hospitals, and corporate clients. Its offerings encompass pathology, radiology, Covid-19 screening, ultrasound, X-rays, and blood analysis. Aspira Pathlab employs a hybrid business model serving both B2C and B2B markets. No information on founders, key management, subsidiaries, or listings is available.
This page is a live market overview for Aspira Pathlab & Diagnostics L (ASPIRA) on the BSE. As a listed security, Aspira Pathlab & Diagnostics L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ASPIRA before placing trades on tick2trade.
As of the latest feed, ASPIRA last traded at ₹106.9 on BSE, down ₹2.15 (1.97%) from the previous close of ₹109.05. Today's session range is ₹106.9 – ₹106.9, against a 52-week band of ₹49 – ₹135.88. Traded volume today stands at 414 shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for ASPIRA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ASPIRA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Aspira Pathlab & Diagnostics L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ASPIRA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ASPIRA option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.